Insulin-like growth factor (IGF)-I and GH measurements are commonly used as biochemical markers of disease activity for diagnosis and follow-up of acromegaly [2]: IGF-I levels are reflective of GH action on peripheral tissue, primarily in the liver, while GH levels reflect somatotroph adenoma secretory activity. Here, IGF1 is linked to acromegaly.